Nanopath
Nanopath is seeking a Software Engineering Co-op to support and manage various software engineering tasks, including motor control, driver development, and test harness creation. The role involves collaborating with a team of scientists and engineers to drive product development while gaining exposure to cutting-edge biophysics and medtech innovation. This is a full-time, onsite position in Cambridge, MA, starting in early January for a duration of at least five months.
Headquarters
Cambridge, Massachusetts, United States
Company Size
11-50 employees
Founded
2019
Nanopath is a diagnostics company focused on women's health that develops advanced molecular testing technologies. The company says it has achieved deep technological breakthroughs—using nano‑enabled approaches—that have the potential to change the molecular diagnostic paradigm. Nanopath aims to translate those innovations into diagnostic platforms and assays that improve sensitivity, speed, and clinical decision‑making in women’s healthcare.
Nanopath Granted FDA Breakthrough Device Designation for Its Molecular Diagnostic Platform for Urinary Tract Infections
Nov 18, 2025
FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
Nov 18, 2025
Nanopath Expands Leadership Team
Nov 12, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nanopath .
Nanopath didn’t post a salary, so this is our estimate from similar listings.
13% below the average for this role
FDA clearances: Dexcom, GE HealthCare, Zimmer Biomet, BrainsWay
Nov 20, 2025